Recent Finacing
Recent Raise
TME Pharma is a clinical-stage biotech developing tumor-microenvironment-targeting therapies (NOX-A12, NOX-E36), advancing GLORIA Phase 1/2 glioblastoma and OPTIMUS pancreatic programs while operating via an outsourced cost-reduction model.
